{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:18:41Z","timestamp":1779322721600,"version":"3.51.4"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,8]]},"abstract":"<jats:p>Overlapping myelodysplastic\/myeloproliferative neoplasms (MDS\/MPN) are clonal hematopoietic disorders with features of myelodysplasia and myeloproliferation. The only well-characterized MDS\/MPN in children is juvenile myelomonocytic leukemia, an aggressive disorder of infants and toddlers. The biochemical hallmark of this disease is hyperactivation of the Ras\/MAPK signaling pathway caused by mutations in Ras pathway genes in more than 90% of patients. Translocations involving receptor tyrosine kinases have been identified in rare cases. Here, we report a 2-year-old patient who presented with MDS\/MPN driven by a cytogenetically cryptic <jats:italic toggle=\"yes\">NUP98-NSD1<\/jats:italic> fusion, a translocation thought to exclusively occur in patients with acute myeloid leukemia.<\/jats:p>","DOI":"10.1097\/mph.0000000000001913","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T20:00:36Z","timestamp":1597867236000},"page":"e808-e811","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["NUP98-NSD1 Driven MDS\/MPN in Childhood Masquerading as JMML"],"prefix":"10.1097","volume":"43","author":[{"given":"Astrid","family":"Behnert","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Benioff Children\u2019s Hospital"},{"name":"Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex G.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Benioff Children\u2019s Hospital"},{"name":"Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth P.","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Benioff Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcus R.","family":"Breese","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Benioff Children\u2019s Hospital"},{"name":"Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanley G.","family":"Leung","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Benioff Children\u2019s Hospital"},{"name":"Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inge","family":"Behroozfard","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Benioff Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Maruffi","sequence":"additional","affiliation":[{"name":"Department of Pediatric Subspecialty, Kaiser Permanente, Oakland, CA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Alejandro","family":"Sweet-Cordero","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Benioff Children\u2019s Hospital"},{"name":"Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Benioff Children\u2019s Hospital"},{"name":"Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Benioff Children\u2019s Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elliot","family":"Stieglitz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Benioff Children\u2019s Hospital"},{"name":"Helen Diller Comprehensive Cancer Center, University of California San Francisco, San Francisco"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,8,18]]},"reference":[{"key":"R1-20250804","doi-asserted-by":"crossref","first-page":"360","DOI":"10.20892\/j.issn.2095-3941.2016.0043","article-title":"Clinical management of myelodysplastic syndrome\/myeloproliferative neoplasm overlap syndromes","volume":"13","author":"Clara","year":"2016","journal-title":"Cancer Biol Med"},{"key":"R2-20250804","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1182\/blood-2014-03-300319","article-title":"Bedside to bench in juvenile myelomonocytic leukemia: insights into leukemogenesis from a rare pediatric leukemia","volume":"124","author":"Chang","year":"2014","journal-title":"Blood"},{"key":"R3-20250804","first-page":"3534","article-title":"Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS)","volume":"89","author":"Niemeyer","year":"1997","journal-title":"Blood"},{"key":"R4-20250804","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1182\/blood.V124.21.613.613","article-title":"A novel fusion gene NDEL1-Pdgfrb in a patient with JMML with a new variant of TKI-resistant mutation in the kinase domain of PDGFR\u03b2","volume":"124","author":"Byrgazov","year":"2014","journal-title":"Blood"},{"key":"R5-20250804","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1038\/s41375-019-0549-y","article-title":"Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing","volume":"34","author":"Chao","year":"2020","journal-title":"Leukemia"},{"key":"R6-20250804","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1182\/blood-2017-07-798157","article-title":"Integrated molecular profiling of juvenile myelomonocytic leukemia","volume":"131","author":"Murakami","year":"2018","journal-title":"Blood"},{"key":"R7-20250804","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1002\/pbc.25342","article-title":"Phase II\/III trial of a pre-transplant farnesyl transferase inhibitor in juvenile myelomonocytic leukemia: a report from the Children\u2019s Oncology Group","volume":"62","author":"Stieglitz","year":"2015","journal-title":"Pediatr Blood Cancer"},{"key":"R8-20250804","doi-asserted-by":"crossref","first-page":"e27034","DOI":"10.1002\/pbc.27034","article-title":"Disease burden and conditioning regimens in ASCT1221, a randomized phase II trial in children with juvenile myelomonocytic leukemia: a Children\u2019s Oncology Group study","volume":"65","author":"Dvorak","year":"2018","journal-title":"Pediatr Blood Cancer"},{"key":"R9-20250804","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bbmt.2014.12.029","article-title":"Chimerism-based pre-emptive immunotherapy with fast withdrawal of immunosuppression and donor lymphocyte infusions after allogeneic stem cell transplantation for pediatric hematologic malignancies","volume":"21","author":"Horn","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"R10-20250804","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1038\/sj.leu.2403104","article-title":"Frequency of NUP98-NSD1 fusion transcript in childhood acute myeloid leukaemia","volume":"17","author":"Cerveira","year":"2003","journal-title":"Leukemia"},{"key":"R11-20250804","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.1182\/blood-2011-04-346643","article-title":"NUP98\/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern","volume":"118","author":"Hollink","year":"2011","journal-title":"Blood"},{"key":"R12-20250804","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/leu.2012.249","article-title":"Analysis of NUP98\/NSD1 translocations in adult AML and MDS patients","volume":"27","author":"Thol","year":"2013","journal-title":"Leukemia"},{"key":"R13-20250804","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.3324\/haematol.2013.100917","article-title":"Potent co-operation between the NUP98-NSD1 fusion and the FLT3-ITD mutation in acute myeloid leukemia induction","volume":"99","author":"Thanasopoulou","year":"2014","journal-title":"Haematologica"},{"key":"R14-20250804","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/ncb1608","article-title":"NUP98-NSD1 links H3K36 methylation to Hox-A gene activation and leukaemogenesis","volume":"9","author":"Wang","year":"2007","journal-title":"Nat Cell Biol"},{"key":"R15-20250804","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/bjh.13869","article-title":"High PRDM16 expression identifies a prognostic subgroup of pediatric acute myeloid leukaemia correlated to FLT3-ITD, KMT2A-PTD, and NUP98-NSD1: the results of the Japanese Paediatric Leukaemia\/Lymphoma Study Group AML-05 trial","volume":"172","author":"Shiba","year":"2016","journal-title":"Br J Haematol"},{"key":"R16-20250804","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1038\/leu.2016.19","article-title":"Identification of MYC mutations in acute myeloid leukemias with NUP98-NSD1 translocations","volume":"30","author":"Lavall\u00e9e","year":"2016","journal-title":"Leukemia"},{"key":"R17-20250804","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/jncimonographs\/lgn014","article-title":"NUP98-HOX translocations lead to myelodysplastic syndrome in mice and men","volume":"39","author":"Slape","year":"2008","journal-title":"J Natl Cancer Inst Monogr"},{"key":"R18-20250804","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1002\/ajh.21373","article-title":"Juvenile myelomonocytic leukemia with t(7;11)(p15;p15) and NUP98-HOXA11 fusion","volume":"84","author":"Mizoguchi","year":"2009","journal-title":"Am J Hematol"},{"key":"R19-20250804","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.leukres.2017.10.010","article-title":"High prognostic value of pre-allogeneic stem cell transplantation minimal residual disease detection by WT1 gene expression in AML transplanted in cytologic complete remission","volume":"63","author":"Candoni","year":"2017","journal-title":"Leukemia Res"},{"key":"R20-20250804","doi-asserted-by":"crossref","first-page":"e27948","DOI":"10.1002\/pbc.27948","article-title":"Molecular assessment of pretransplant chemotherapy in the treatment of juvenile myelomonocytic leukemia","volume":"66","author":"Hecht","year":"2019","journal-title":"Pediatr Blood Cancer"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T20:10:21Z","timestamp":1754338221000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MPH.0000000000001913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,18]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0000000000001913","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8,18]]},"assertion":[{"value":"2020-05-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-06-28","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}